Serum ferritin as an independent biomarker of subclinical synovitis in rheumatoid arthritis patients in clinical remission or low disease activity
Duygu Kurtulus, Adem Kucuk · 2026
Read Serum ferritin as an independent biomarker of subclinical synovitis in rheumatoid arthritis patients in clinical remission or low disease activity by Duygu Kurtulus, Adem Kucuk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616694.txt.
Description
Duygu Kurtulus and Adem Kucuk test serum ferritin as a biomarker of subclinical synovitis in rheumatoid arthritis in a 2026 study. Joints can stay inflamed under the skin long after a patient feels well and scores read low. The usual blood marks of inflammation can miss that hidden fire. Ultrasound with Doppler can see it, but a blood sign would be cheaper to track.
Ferritin, a protein that stores iron and rises with inflammation, is their candidate. Patients in remission or low disease activity had joints scanned and blood drawn. Ferritin levels were then set against the scan signs of live synovitis. The protein stands on its own as a mark, the team report.
Catalog record
| CREATOR | Duygu Kurtulus, Adem Kucuk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |